Thyroid cancer
Conditions
Interventions
R group:Continuous intraoperative infusion of rocuronium bromide (3 µ g/kg/min)
Sponsors
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: ASA I-II grade, 18-50 year old patients planning to undergo thyroid cancer radical surgery
Exclusion criteria
Exclusion criteria: (1) Patients with previous neuromuscular diseases; (2) Patients with previous recurrent laryngeal nerve injury or vocal cord paralysis; (3) Patients with preoperative liver and kidney dysfunction; (4) Identify patients who are allergic to rocuronium bromide; (5) Patients with combined peripheral neuromuscular diseases, a history of forearm and distal surgery, and inability to undergo muscle relaxation monitoring;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative satisfaction rating; | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in success rates of neural monitoring;Differences in amplitude of neural stimulation signals;Differences in postoperative extubation time and adverse reactions during the recovery period; | — |
Countries
China
Contacts
Public ContactHe Kai
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Outcome results
None listed